Latest

medicine

Featured Neurology Neuroscience Open Neuroscience Articles

·January 30, 2020·3 min read

Immune response in brain and spinal cord could offer clues to treating neurological diseases

Microglia can interfere with macrophages, preventing the movement of these blood immune cells to injury sites. The findings could help in the development of new treatments for multiple sclerosis, Alzheimer's disease, and spinal cord injury.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 29, 2020·4 min read

New injection technique may boost spinal cord injury repair efforts

Researchers have developed a new method for delivering neural precursor cells into rat models of spinal cord injury. The method is safe, effective, and reduces the likelihood of further spinal trauma while delivering larger doses of reparative stem cells. The new approach could also be used for the treatment of ALS and multiple sclerosis.

Featured Neurology Neuroscience

·January 27, 2020·3 min read

New look at odd holes involved in taste, Alzheimer’s, and asthma

Microscopy study sheds light on the function of two calcium homeostasis modulators.

Featured Genetics Neurology Neuroscience Pain

·January 25, 2020·2 min read

First treatment for pain using human stem cells a success

Transplanting GABAergic cells derived from human-induced pluripotent stem cells into mice resulted in safe, lasting, and effective relief from extreme neuropathic pain. Researchers hope to begin human testing within five years.

This shows an old man sitting on a park bench

Featured Neurology Neuroscience

·January 25, 2020·5 min read

Lithium may halt Alzheimer’s progression

More commonly associated with treating bipolar disorder, microdoses of lithium may halt the progression of Alzheimer's disease.

Brain Cancer Featured Neurology Neuroscience Open Neuroscience Articles

·January 23, 2020·2 min read

Unexpected connection between gliomas and neurodegenerative diseases

Study finds significant expression of the Alzheimer's related Tau protein in glioma cells, especially in patients with better prognoses.

This shows two clocks set one hour apart

Brain Cancer Featured Neurology Neuroscience

·January 21, 2020·2 min read

Chronobiologists warn of health risks linked to daylight saving

Chronobiologists warn changing to daylight savings can have serious effects on both brain and general health. The change in time during spring was linked to a 24% increase in severe cardiovascular events in women. Researchers also noted the sudden change in time alters circadian rhythms, reduces the production of natural melatonin, impacts cognitive function, and may also foster tumor growth.

This shows an older woman with a walking stick

Featured Neurology Neuroscience

·January 20, 2020·5 min read

Racial disparities in drug prescriptions for dementia

Study reveals racial disparities in access to the correct medications for Alzheimer's patients. Asian and black patients are less likely to be prescribed anti-dementia medications and have an increased likelihood of being prescribed antipsychotic medications.

This shows two heads and a swirly background

Featured Neuroscience Psychology

·January 20, 2020·2 min read

New research confirms lingering mood benefit of psychedelics

Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness, after the effect of the drug has worn off.

This shows amyloid beta and aluminum traces in the brain sample

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 20, 2020·3 min read

Human Exposure to Aluminum Linked to Familial Alzheimer’s Disease

Researchers found a close association between high aluminum content in brain tissue and amyloid-beta location in post-mortem samples of people with familial Alzheimer's disease. The findings back up previous claims that aluminum exposure may be linked to the development of the neurodegenerative disease.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 17, 2020·3 min read

New insights into a Parkinson’s disease protein

Alpha synuclein's non-amyloidal component (NAC) aids the protein's movement through axons. When the NAC region is removed, alpha-synuclein did not move within axons.